Latigo Biotherapeutics, Inc.
LTGO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002056611
In the last 90 days, Latigo Biotherapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Latigo Biotherapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $2.52M in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$2.52M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Latigo Biotherapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Schwab Andrew J. | 10% Owner | 2,350,419Indirect | Aug 12, 2026 | 1 |
| Parmar Kush | 10% Owner | 2,350,419Indirect | Aug 12, 2026 | 1 |
| 5AM Ventures VI, L.P. | 10% Owner | 2,350,419Indirect | Aug 12, 2026 | 1 |
| 5AM Partners VI, LLC | 10% Owner | 2,350,419Indirect | Aug 12, 2026 | 1 |
| 5AM Opportunities II, L.P. | 10% Owner | 2,350,419Indirect | Aug 12, 2026 | 1 |
| 5AM Opportunities II (GP), LLC | 10% Owner | 2,350,419Indirect | Aug 12, 2026 | 1 |
| Sanofi | 10% Owner | 672,788Indirect | Aug 12, 2026 | 1 |
| Westlake BioPartners Fund I, L.P. | 10% Owner | 2,094,813Indirect | Aug 11, 2026 | 1 |
| Westlake BioPartners Opportunity GP I, LLC | 10% Owner | 2,094,813Indirect | Aug 11, 2026 | 1 |
| Westlake BioPartners Opportunity Fund I, L.P. | 10% Owner | 2,094,813Indirect | Aug 11, 2026 | 1 |
| Westlake BioPartners Fund II, L.P. | 10% Owner | 2,094,813Indirect | Aug 11, 2026 | 1 |
| Westlake BioPartners GP II, LLC | 10% Owner | 2,094,813Indirect | Aug 11, 2026 | 1 |
| Westlake BioPartners GP I, LLC | 10% Owner | 2,094,813Indirect | Aug 11, 2026 | 1 |
| Foresite Capital Fund V, L.P. | 10% Owner | 3,414,544Indirect | Aug 10, 2026 | 1 |
| Foresite Capital Opportunity Fund V, L.P. | 10% Owner | 3,414,544Indirect | Aug 10, 2026 | 1 |
| Foresite Capital Management V, LLC | 10% Owner | 3,414,544Indirect | Aug 10, 2026 | 1 |
| Foresite Capital Opportunity Management V, LLC | 10% Owner | 3,414,544Indirect | Aug 10, 2026 | 1 |
| Foresite Capital Fund VI LP | 10% Owner | 3,414,544Indirect | Aug 10, 2026 | 1 |
| Foresite Capital Management VI LLC | 10% Owner | 3,414,544Indirect | Aug 10, 2026 | 1 |
| Smith Todd N | Director | – | Aug 10, 2026 | 1 |
| Tananbaum James B. | Director, 10% Owner | 3,414,544Indirect | Aug 10, 2026 | 1 |
| Seidenberg Beth C | Director, 10% Owner | 2,094,813Indirect | Aug 10, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 (view filing)8:21 PM ET | Aug 10 | Same day | Foresite Capital Fund V, L.P. and 5 others10% Owner | PPurchase | +140.0K | $18.00 | +$2.52M | +7.5%2.01M after | Duplicate filing |
| Aug 10, 2026 (view filing)8:00 PM ET | Aug 10 | Same day | Tananbaum James B.Director, 10% Owner | PPurchase | +140.0K | $18.00 | +$2.52M | +7.5%2.01M after |